NARATRIPTAN-1A Pharma for migraine 2.5 mg film-coated tablets, 2 pcs

Instructions for use for NARATRIPTAN-1A Pharma for migraine 2.5 mg film-coated tablets, 2 pcs

Naratriptan 1A Pharma for migraine 2.5 mg film-coated tablets are used to treat the headache phase of migraine attacks. The active substance naratriptan belongs to the group of 5-HT1B/1D receptor agonists. It is recommended to take one film-coated tablet (2.5 mg) at the first sign of a migraine attack. If the first film-coated tablet has no effect, another film-coated tablet may be taken within 24 hours. However, no more than 2 film-coated tablets should be taken within 24 hours. Naratriptan 1A Pharma for migraine is not suitable for the prevention of migraine attacks. The medicine should not be used in children and adolescents under 18 years of age or in people over 65 years of age. Before taking the medicine, the package leaflet should be read carefully and a doctor or pharmacist should be consulted in case of uncertainty. People who are allergic to naratriptan or to any of the ingredients of the medicinal product should not take naratriptan. Other contraindications include certain heart and circulatory disorders and kidney or liver disease. The medicine may cause side effects such as gastrointestinal discomfort, dizziness, tiredness and visual disturbances. It is important not to exceed the maximum dosage of 2 film-coated tablets within 24 hours. It should be stored out of the reach of children. The information is taken from the package leaflet, as of 10/2019.